Exposure to estrogen during the developmental period causes reproductive dysfunction in mammals, because the developing brain is highly sensitive to estrogens. In the present study, we report that longterm exposure to supraphysiological doses of estrogen during the neonatal critical period causes irreversible suppression of Kiss1/kisspeptin expression in the arcuate nucleus (ARC) via estrogen receptoralpha (ERa) and ERb, resulting in reproductive dysfunction in female rats. Daily estradiol-benzoate (EB) administration from days 0 to 10 postpartum caused persistent vaginal diestrus in female rats. The female rats showed profound suppression of pulsatile luteinizing hormone (LH) release and ARC Kiss1/ kisspeptin expression even after ovariectomy at adulthood. In contrast, female rats treated with a single EB injection at day 5 postpartum exhibited persistent vaginal estrus and showed comparable LH pulses and numbers of ARC Kiss1-expressing cells to vehicle-treated controls after ovariectomy at adulthood. Because the LH secretory response to exogenous kisspeptin was spared in female rats with neonatal long-term estrogen exposure, the LH pulse suppression was most probably due to ARC kisspeptin deficiency. Furthermore, neonatal estrogen might act through both ERa and ERb, because EB exposure significantly reduced the number of ARC Kiss1-expressing cells in wild-type mice but not in ERa or ERb knockout mice. Taken together, long-term exposure to supraphysiological doses of estrogen in the developing brain might cause defects in ARC kisspeptin neurons via ERa and ERb, resulting in inhibition of pulsatile LH release and lack of estrous cyclicity. (Endocrinology 158: 2918(Endocrinology 158: -2929(Endocrinology 158: , 2017 
I
t is clear that estrogen acts on the developing brain to play a critical role in sexual differentiation, neural growth, neuroprotection, and neuromodulation by preventing or promoting apoptosis and synaptogenesis of the neurons and glial cells, owing to the brain's high sensitivity to estrogens (1) . Thus, aberrant exposure to hormonally active substances, such as endocrine disrupting compounds, during the fetal or perinatal critical period could result in improper hypothalamic programming, decreasing reproductive ability later in life (2) (3) (4) . It has been demonstrated that exposure to estrogenlike compounds during developmental periods might be a factor in the decrease in human fertility (5) .
Experimental studies using female rodent models showed that exposure to estrogenic chemicals during the neonatal period led to hypogonadotropic hypogonadism, followed by a disruption in estrous cyclicity and infertility in adulthood (6) (7) (8) . These findings suggest that estrogen exposure in early-life stages causes deficiencies in follicular development and/or the ovulation system, which are regulated by the central nervous system controlling gonadotropin-releasing hormone (GnRH)/gonadotropin release later in life. Uncovering the neuroendocrine mechanism mediating irreversible estrogen actions in the developing brain is an important issue in terms of the clinical and physiological aspects.
Kisspeptin-GPR54 signaling has been considered a gatekeeper of puberty, because mutations of Gpr54 and Kiss1 genes in human and rodent models cause failure of puberty and reproductive dysfunction at adulthood (9) (10) (11) (12) (13) (14) . Kisspeptin is a key player in reproduction via direct stimulation of GnRH and subsequent gonadotropin release in mammalian species, including nonhuman primates, ruminants, and rodents (14) (15) (16) (17) (18) . Exposure to estrogen or androgen during the neonatal critical period defeminizes kisspeptin neurons in the anteroventral periventricular nucleus (AVPV), resulting in an abolishment of the luteinizing hormone (LH) surge in female rats (19, 20) . The AVPV kisspeptin neurons, therefore, are closely involved in the generation of the GnRH/gonadotropin surge. Previous studies have shown that a single estrogen or androgen treatment in the neonatal period significantly reduced Kiss1 expression in the AVPV in adult female rats but failed to affect expression in the arcuate nucleus (ARC) kisspeptin neurons (19, 20) . The latter are considered an intrinsic GnRH/gonadotropin pulse generator regulating gametogenesis and steroidogenesis in male and female mammals (14-16, 18, 21) . Navarro et al. (22) showed that neonatal administration of an environmentally relevant estrogen, bisphenol A, and estradiol benzoate (EB) at postpartum day 1 suppressed Kiss1 expression in the whole hypothalamus of rats in the prepubertal period. Furthermore, Bateman and Patisaul (23) showed that the density of kisspeptin immunoreactive fibers in the ARC decreased with daily neonatal EB treatment at postnatal days 0 to 3 in rats. These results suggest that inappropriate exposure to estrogenic chemicals can lead to irreversible suppression of Kiss1 expression in both the anterior (AVPV) and posterior (ARC) populations of kisspeptin neurons, resulting in dysfunction of both GnRH/LH surge and pulse generators in later life. Thus, the ARC kisspeptin neurons could also be a target of estrogen during the developmental period in mammals. Animal models exposed to supraphysiological doses of estrogen would be useful to clarify the effects of environmental exposure to high levels of estrogenic chemicals during the developmental period on reproductive function later in life.
Thus, the present study investigated the effects of longterm exposure to supraphysiological doses of estrogen during the neonatal period on ARC kisspeptin neurons and pulsatile LH release in adulthood in female rats. We also determined the effect of a single estrogen treatment on ARC kisspeptin expression and LH pulses to examine whether the response of ARC kisspeptin neurons to the single neonatal EB injection differs from the response to long-term EB exposure. The LH secretory capacity in response to kisspeptin challenge in long-term EB-treated rats was investigated to determine whether the kisspeptin downstream effectors function properly. Furthermore, estrogen receptor a (ERa) and ERb knockout (KO) mice were also subjected to exposure to long-term neonatal estrogen to examine whether the ERs mediate the neonatal estrogeninhibiting action on ARC Kiss1 expression in later life.
Materials and Methods

Animals
Wistar-Imamichi strain female rats (Charles River Laboratories Japan, Inc., Kanagawa, Japan) and B57BL/6 wild-type (WT) and ERa or ERb KO female mice (The Jackson Laboratory, Bar Harbor, ME) were used and were housed in a controlled environment (14-hour/10-hour light/dark cycle; lights on at 5:00 AM; temperature maintained at 22°6 2°C) with free access to food and water. Some ERa or ERb KO mice used in the present study had been backcrossed three times with Crl:CD1 mice (Charles River Laboratories Japan, Yokohama, Japan). The animals underwent surgical procedures under isoflurane or ketamine anesthesia in adulthood and cryoanesthesia on ice in the neonatal stage. The committee on animal experiments of the Graduate School of Bioagricultural Sciences, Nagoya University, approved the present experiments.
Effects of long-term and single estrogen treatment on reproductive function in female rats
Adult female rats were mated with male rats on the day of proestrus. The day of parturition was designated as day 0. Newly born female rats were injected subcutaneously daily with EB (Sigma-Aldrich, St. Louis, MO) at a dose of 10 mg on days 0 to 3, 25 mg on days 4 to 6, and 50 mg on days 7 to 10 dissolved in 50 mL of peanut oil. These doses were chosen in accordance with previous studies, in which neonatally estrogenized rats (10 mg of EB on days 1 to 5) showed persistent diestrus. The doses were adjusted according to the body weight changes. Vehicle-treated control rats were injected daily with 50 mL of peanut oil on days 0 to 10. Some neonatal female rats received a single subcutaneous injection of 25 mg of EB on day 5. That dose of EB was chosen in accordance with previous studies showing that EB treatment on day 5 attenuated the AVPV kisspeptin neurons and abolished the LH surge in female rats (19, 24) . All the animals were weaned on day 20 and underwent ovariectomy (OVX) at age 9 to 11 weeks to remove the influence of endogenous gonadal steroids. Some animals were weighed every 7 days, and the vaginal smears were daily examined after vaginal opening had occurred to determine estrous cyclicity.
Two weeks after OVX, blood samples were collected for 3 hours at 6-minute intervals from freely moving conscious rats from 1:00 PM onward to detect pulsatile LH release. Blood samples (100 mL) were taken from a right atrial cannula (inner diameter, 0.5 mm; outer diameter, 1.0 mm; Shin-Etsu Polymer, Tokyo, Japan) that had been inserted into the jugular vein on the day before the blood samples were taken. Each blood sample was replaced with an equivalent volume of washed red blood cells obtained from other Wistar-Imamichi strain rats to maintain a constant hematocrit level. Some OVX rats that had received neonatal long-term EB injections were bled for 3 hours after the intracerebroventricular challenge of 0.1 and 1 nmol of full-length rat kisspeptin (Phoenix Pharmaceuticals, Inc., Burlingame, CA) dissolved in 2 mL of ultra-pure water (UPW). We performed this experiment to determine the LH secretory capacity in response to exogenous kisspeptin to discover whether downstream effectors, such as GnRH neurons and pituitary gonadotrophs, would function properly.
Effects of neonatal long-term and single EB treatment on Kiss1/kisspeptin, Gpr54, Tac3, Pdyn, tyrosine hydroxylase, and GnRH expression in female rat brain in adulthood Medial basal hypothalamus tissues primarily containing the ARC-median eminence region (ARC-ME) from female rats that had undergone neonatal long-term or single EB treatment were dissected from the brain, as described previously (19) . Kiss1 and Gpr54 messenger RNA (mRNA) levels in ARC-ME were quantified using quantitative real-time polymerase chain reaction (qPCR), as described previously (19, 25, 26) . b-Actin was used as the internal control. All primer sequences are described in Supplemental Table 1 . Kiss1 and kisspeptin expression in the ARC region in each group was also determined by in situ hybridization and immunohistochemistry, respectively, as described previously (14, 19, (25) (26) (27) . Tac3 and Pdyn expression in the ARC of female rats in each group was also determined by in situ hybridization. Furthermore, tyrosine hydroxylase (TH) and GnRH immunoreactivity in the ARC-ME of these rats was determined using specific antibodies to TH and GnRH, as described previously (28, 29) .
Analysis of ER subtype mediating inhibitory action of neonatal long-term EB treatment on ARC Kiss1 expression using ER KO mice Newly born WT, ERa KO, and ERb KO female mice were subcutaneously injected with EB at a dose of 7.5 mg on days 1 and 3, 15 mg on days 5 and 7, and 22.5 mg on day 9 dissolved in 20 mL of peanut oil. The dose was adjusted to the mouse body weight and the dose used in rats (19, 24) . Control mice were injected with the same volume of peanut oil. Mice aged 8 to 12 weeks underwent OVX 1 week before brain sampling. The brain sections were subjected to in situ hybridization to determine the difference in the effect of neonatal EB treatment on ARC Kiss1 mRNA expression among ER genotypes.
In situ hybridization
OVX rats and mice were deeply anesthetized with sodium pentobarbital and perfused with 0.9% saline followed by 4% paraformaldehyde. The brains were removed immediately, postfixed in the same fixative overnight at 4°C, and immersed in 30% sucrose in 0.05 M phosphate buffer at 4°C. Serial coronal sections (50 mm thick) containing the ARC-ME were obtained using a cryostat. Every fourth section through the ARC (rat, from 1.72 mm to 4.36 mm posterior to the bregma; mouse, from 1.23 mm to 2.79 mm posterior to the bregma) taken from each animal according to the rat or mouse brain atlas (30, 31) were subjected to analysis. Kiss1, Tac3, and Pdyn mRNA expression in the ARC of rats and Kiss1 mRNA expression in the ARC of mice were detected by free-floating in situ hybridization using specific digoxigenin (DIG)-labeled probes, as described previously (19, 25, 26, 32, 33) . DIG-labeled antisense complementary RNA probes for rat Kiss1 (position 33-348; GenBank accession no. NM_181692), Tac3 (position 180-483; GenBank accession no. NM_019162), Pdyn (position 315-731; GenBank accession no. NM_019374), and mouse Kiss1 (position 60-372; GenBank accession no. NM_178260) were synthesized by in vitro transcription from rat or mouse hypothalamic complementary DNA using a DIG-labeling kit (Roche Diagnostics, Basel, Switzerland). In brief, the brain sections were treated with 1 mg/mL protease K and 0.25% acetic anhydride in 0.1 M triethanolamine and hybridized with 1 mg/mL DIG-labeled probes. The sections were treated with 20 mg/mL RNase A, immersed in 1.5% blocking reagent solution (Roche), and then incubated with an alkaline phosphatase-conjugated anti-DIG antibody (1:1000; Roche; Research Resource Identification [RRID]: AB_514497). The sections were treated with a chromagen solution (337 mg/mL 4-nitroblue tetrazolium chloride and 175 mg/mL 5-bromo-4-chloro-3-indoyl-phosphate; Roche) until a visible signal was detected. After processing, the sections were mounted and examined using an optical microscope (model no. BX51; Olympus, Tokyo, Japan).
Immunohistochemistry for kisspeptin, GnRH, and TH
Female rats that had undergone OVX 2 weeks before brain sampling, stereotaxically received a lateral cerebroventricular injection (0.8 mm posterior and 2.5 to 3.5 mm ventral to the bregma and 1.3 mm lateral from the midline) of colchicine (75 mg/15 mL saline; Wako Chemicals, Richmond, VA) to visualize kisspeptin-and TH-immunoreactive cells. Two days after injection, the rat brains were collected, and serial coronal sections (50 mm thick) containing the ARC-ME were obtained using a cryostat. Every fourth section through the ARC (from 1.72 mm to 4.36 mm posterior to the bregma) taken from each rat according to the rat brain atlas were subjected to immunohistochemistry with an anti-kisspeptin mouse monoclonal antibody (1:50,000; Takeda no. 254; kindly donated by Takeda Pharmaceutical Co., Osaka, Japan; RRID: AB_2636957) or anti-TH mouse monoclonal antibody (1:2000; Chemicon International, Temecula, CA; RRID: AB_2201528), respectively. The sources and concentrations of antibodies used in these studies are listed in Table 1 . The sections were subsequently incubated with biotinylated horse anti-mouse immunoglobulin G (IgG) antibody (Vector Laboratories, Burlingame, CA; RRID: AB_2313581) for 1.5 hours. They were then incubated with an avidin-biotinylated horseradish peroxidase complex (VECTASTAIN Elite ABC Standard Kit; Vector Laboratories) for 1 hour. The sections were then visualized with 0.02% diaminobenzidine mixed with 0.006% hydrogen peroxide. Bright-field images of the sections were obtained using an optical microscope (model BX51; Olympus).
To visualize GnRH, brain sections were obtained from OVX rats without colchicine injection. The sections were incubated with anti-GnRH mouse monoclonal antibody [1:2000; LRH13; kindly provided by Dr. M. K. Park, University of Tokyo, Tokyo, Japan (28); RRID: AB_2636958] followed by incubation with secondary antibodies conjugated with Alexa Fluor 488 (Molecular Probes, Eugene, OR; RRID: AB_141607). Fluorescence images were obtained using an ApoTome microscope (Carl Zeiss, Jena, Germany).
LH assay
Plasma LH concentrations were determined using a double antibody radioimmunoassay with a rat LH radioimmunoassay kit provided by the National Hormone and Pituitary Program (Baltimore, MD) and expressed in terms of National Institutes of Diabetes and Digestive and Kidney Diseases rLH-RP-3. The least detectable level of LH was 0.156 ng/mL for 50-mL plasma samples. The intra-and interassay coefficients of variation were 5.3% at 4.9 ng/mL and 10.7% at 2.03 ng/mL, respectively.
Statistical analysis
LH pulses were identified using the PULSAR computer program, as previously described (34) (35) (36) . To count the number of kisspeptin-or TH-immunoreactive cells and Kiss1-, Tac3-, or Pdyn-expressing cells, all ARC sections were counted, and 1 value per animal was used for statistical analysis. Statistically significant differences in the percentage of proestrus, estrus, and diestrus during the estrous cycle, each LH pulse parameter, Kiss1 and Gpr54 mRNA levels analyzed by qPCR, cell number expressing Kiss1, Tac3, or Pdyn mRNA and kisspeptin or TH among vehicle, EB 5, and EB 0 to 10 groups were determined using one-way analysis of variance (ANOVA), followed by the Tukey honest significant difference test. To evaluate rat kisspeptin-induced LH secretion, areas under the curve (AUCs) for the plasma LH concentration were calculated during the 3-hour sampling period for each animal. Statistically significant differences in the AUCs between the vehicle and EB 0 to 10 groups were determined using two-way ANOVA (neonatal treatment and dose of kisspeptin as main factors), followed by the Bonferroni test. Statistically significant differences in the number of Kiss1-expressing cells among WT, ERa KO, and ERb KO mice were determined by two-way ANOVA (neonatal treatment and genotype as the main factors), followed by the Bonferroni test. To calculate areas of GnRH immunoreactivity in the vehicle and EB 0 to 10 groups, all digital photomicrographs of each rat ARC-ME were processed using ImageJ software (National Institutes of Health, Bethesda, MD). The fluorescence image of the ARC-ME was outlined on the grayscale image and processed for area density measurement. After nonspecific background density points were eliminated by setting a threshold, the area density was calculated as the total number of pixels with a fluorescence intensity value greater than the threshold. The total fluorescence intensity was calculated as a single value for each animal for statistical analysis. The statistically significant difference in the area of GnRH immunoreactivity between vehicle and EB 0 to 10 groups were determined using Student's t test.
Results
Effects of long-term or single EB administration at the neonatal stage on estrous cyclicity and LH release in female rats Figure 1 shows the results of vaginal smear observations of representative animals in each group. Female rats receiving neonatal daily EB administration showed persistent vaginal diestrus later in life for #60 days [ Fig. 1(a) ], resulting in a significantly greater percentage of diestrous phase and lower percentage of proestrus and estrous phases compared with that of neonatally oiltreated control rats showing regular 4-day estrous cycles [ Fig. 1(b) ]. However, the rats treated with a single EB injection at day 5 showed persistent vaginal estrus [ Fig. 1(a) ], resulting in percentage of estrus that was significantly greater compared with both oil-injected and long-term EB-treated female rats [ Fig. 1(b) ].
Figure 2(a) shows the profile of LH release in representative OVX rats in each group. No LH pulse was observed in adult rats that had received neonatal longterm EB treatment. However, apparent LH pulses were observed in oil-treated controls [ Fig. 2(a) ]. All LH pulse parameters, including the mean LH levels, baseline LH levels, and frequency and amplitude of LH pulse, in the rats with neonatal long-term EB treatment were significantly lower than those of the controls [ Fig. 2(b) ]. However, the rats treated with a single neonatal EB injection showed regular LH pulses in adulthood [ Fig. 2(a) ], resulting in significantly greater levels in the pulse parameters, such as the mean LH levels and frequency and amplitude of the LH pulse compared with those in the rats with long-term EB treatment. The frequency and amplitude of the LH pulses in the single-neonatal EB-injected rats were comparable to those in the oil-treated control rats, although the mean and baseline LH levels were significantly lower than those in the controls [ Fig. 2(b) ].
The daily body weight change in rats with neonatal long-term or single injection of EB was comparable to that of oil-treated controls, indicating that the difference in LH release between the groups was not from changes in their body growth (Supplemental Fig. 1 ).
Effects of neonatal EB treatment on Kiss1/kisspeptin and Gpr54 expression in female rat brain Figure 3 (a) shows Kiss1-expressing and kisspeptinimmunoreactive cells in the ARC of representative OVX rats at adulthood in each group. Few Kiss1-expressing and kisspeptin-immunoreactive cells were found in the ARC of rats treated neonatally with long-term EB. In contrast, abundant cells were found in oil-treated controls and rats treated neonatally with single EB injection [ Fig. 3(a) ]. Thus, the numbers of Kiss1-expressing and kisspeptin-immunoreactive cells in the long-term EBtreated rats were significantly lower compared with those in the oil-treated and single EB-treated rats [ Fig. 3(b) ]. The number of ARC kisspeptin-immunoreactive cells in the single EB-treated rats was significantly greater than that in the oil-and long-term EB-treated rats. The number of Kiss1-expressing cells showed no statistically significant difference between the oil-and single EB-treated rats. Figure 3 (c) shows Kiss1 and Gpr54 mRNA levels determined by qPCR in the ARC-ME of the OVX rats in each group. Kiss1 mRNA levels in the ARC-ME of the rats with neonatal long-term EB treatment was significantly lower than those of oil-injected or single EB-injected OVX rats. The Kiss1 mRNA level in single EB-treated rats was significantly lower than that in oil-treated rats. The Gpr54 mRNA levels in the ARC-ME were comparable among the groups.
Effects of neonatal EB treatment on TH, Tac3, and Pdyn expression in female rat brain Figure 4 (a) shows the effect of neonatal EB administration on TH immunoreactivity in the ARC-ME in female rats at adulthood. TH-immunoreactive cells were identifiable in the ARC of all the groups. No substantial difference was found in the number of TH-immunoreactive cells among the groups [Fig. 4(b) ]. Figure 4(c) shows the Tac3 and Pdyn mRNA expression in the ARC of representative female rats in each group at adulthood. A number of Tac3-and Pdynexpressing cells were found in the ARC of both oil-and single EB-treated animals. In contrast, few Tac3 and Pdyn signals were detected in the ARC from long-term EBtreated animals. The numbers of both Tac3-and Pdynexpressing cells from long-term EB-treated rats were significantly lower than those from oil-and single EBtreated rats [ Fig. 4(d) ].
LH responses to exogenous kisspeptin challenge in neonatal long-term EB-treated female rats
Kisspeptin challenge immediately stimulated LH release in a dose-dependent manner in female rats treated with neonatal long-term EB and in controls treated with neonatal oil only [ Fig. 5(a) ]. A higher dose (1 nmol) of kisspeptin significantly increased LH release in both groups (neonatal EB or oil treatment) compared with UPW-injected corresponding controls [ Fig. 5(b) ]. The AUC of the LH levels in the neonatal long-term EBtreated rats was significantly lower than that of oiltreated controls. Although the relative responses (fold changes) to the kisspeptin challenge compared with the corresponding vehicle-injected controls was higher in neonatal EB-treated rats (;7.6-fold) than in neonatal oiltreated controls [;3.0-fold; Fig. 5(c) ]. Dense GnRHimmunopositive fibers were found in the ME of female rats with neonatal long-term EB treatment and in the oil-treated controls [ Fig. 5(d) ]. The ME GnRH-immunoreactive area in females that had received neonatal long-term EB treatment was significantly higher than that in controls [ Fig. 5(e) ].
Involvement of ERa and ERb in EB-induced reduction of Kiss1 expression in neonatal EB-treated female mice
Figure 6(a) shows the Kiss1 expression in the ARC of representative WT, ERa KO, and ERb KO mice. Neonatal long-term EB treatment caused a marked reduction in the number of Kiss1-expressing cells in the ARC of WT mice. In contrast, a number of Kiss1-expressing cells were found in the ARC of ERa and ERb KO mice with 
Discussion
The results of the present study have demonstrated that the ARC kisspeptin neuron is a target of neonatal long-term EB exposure, which causes profound suppression of kisspeptin expression in later life. This suppression results in LH pulse suppression in adulthood. Exogenous kisspeptin challenge induced LH release in these female rats treated neonatally with long-term EB. In these female rats, hypothalamic Gpr54 expression was comparable to that of the vehicletreated controls. Furthermore, GnRH immunoreactivity in the ME was even greater in the long-term EB-treated rats than in the oil-treated controls, suggesting that GnRH was produced but its releasing mechanism was disrupted. The results of the present study have shown that suppression of ARC Kiss1/kisspeptin expression induced by neonatal long-term EB exposure resulted in strong inhibition of LH pulses in female rats. This is consistent with the notion that ARC kisspeptin neurons are a putative intrinsic source of the GnRH/LH pulse generator (14-16, 18, 21) , which is indispensable for maintaining normal reproductive function in mammals (21) . In contrast, single neonatal EB administration spared ARC kisspeptin expression and LH pulses in female rats, suggesting that chronic exposure to EB somehow triggers irreversible and profound suppression of Kiss1/kisspeptin expression in ARC kisspeptin neurons and, subsequently, LH pulses. The current single EB treatment partially suppressed the LH pulses, including the baseline and mean LH levels of LH pulses, in adulthood. LH pulse suppression could have resulted from the partial suppression of ARC Kiss1 expression, because qPCR analysis revealed that single EB exposure significantly decreased ARC Kiss1 expression in adulthood. Neonatal single EB treatment caused an increase in the number of ARC kisspeptin-immunoreactive cells in adulthood. This suggests that single exposure to high EB during the neonatal period might cause an inhibitory pathway to suppress kisspeptin release from ARC kisspeptin neurons and then LH pulses. Our previous study showed that the ARC kisspeptin immunoreactive density in OVX rats treated with a diestrous level of estrogen, whose LH release was suppressed by estrogen negative feedback, was greater than that of OVX rats (32) .
The animals that underwent neonatal single EB treatment showed persistent vaginal estrus, suggesting that the GnRH/LH surge-generating mechanism was Values with different letters are significantly (P , 0.05) different from each other (one-way ANOVA, followed by Tukey honest significant difference test). Scale bars = 100 mm. D, diestrus; E, estrus; EB 0-10, female rats received neonatal daily EB administration during neonatal period from days 0 to 10 after birth; EB 5, female rats received neonatal single EB administration at day 5 after birth; Oil 0-10, female rats received neonatal daily vehicle administration during neonatal period from days 0 to 10 after birth; P, proestrus.
disrupted by short-term estrogen exposure. This result is consistent with previous studies showing that short-term exposure to estrogen or androgen inhibits the estrogeninduced LH surge and Kiss1 expression of AVPV kisspeptin neurons, considered to be a part of the GnRH/ LH-surge generating system (19, 20) . The difference in effects between single and long-term EB exposure on both ARC kisspeptin expression and LH pulses suggests that AVPV kisspeptin neurons are more sensitive to estrogen than are the ARC kisspeptin neurons in the developmental period. Thus, suppression of Kiss1/kisspeptin expression in the ARC is induced by longer exposure of estrogen than that in the AVPV. Therefore, the difference in the effects of neonatal short-term and long-term EB exposure on estrous cyclicity accounted for the difference in the sensitivity and/or critical windows of estrogen exposure between AVPV and ARC kisspeptin neurons. Previous studies using rodent models showed that neonatal injection of EB induced sterility (persistent estrus or diestrus) but the effect was dependent on the amount and period of EB treatment (7) . The critical period of neonatal steroid treatment to defeminize the AVPV Kiss1 neurons might be extended at least to day 5 postpartum, because previous studies have shown that a single administration of EB at 5 days after birth caused persistent estrous in female rats (6) , and a single EB administration from embryonic day 21 to postnatal day 5, but not postnatal day 10, completely abolished the E2-induced LH surge (24) . Folliculogenesis was observed in ovaries treated with a single 100-mg EB administration at postnatal day 3 (7), and daily 25-mg EB administration from days 0 to 3 caused persistent diestrus in female rats (8) , as did long-term EB treatment in the present study. These findings suggest that at least partial overlap might exist in the critical windows to estrogen exposure between AVPV and ARC kisspeptin neurons during postnatal days 0 to 3.
The present study showed that GnRH immunoreactivity in the ME of longterm EB-treated animals was greater than that of oil-treated controls, suggesting that GnRH peptide accumulated in the GnRH nerve terminals located in the ME owing to inhibition of GnRH release caused by suppression of ARC Kiss1/kisspeptin. This interpretation was supported by a previous report showing that GnRH immunoreactivity in the ME declined with an increase in GnRH/gonadotropin release after OVX (37) . Furthermore, in the present study, the long-term EB-treated animals retained the dose-dependent effect of the LH https://academic.oup.com/endoresponse to kisspeptin. In contrast, the amount of LH release indicated by the AUC was lower than that in oiltreated controls. These results suggest that early exposure to exogenous estrogens decrease adult pituitary responsiveness to GnRH. This finding is consistent with those from previous studies, which showed that neonatal exposure to diethylstilbestrol (DES), an artificial estrogen, decreased GnRH-stimulated LH secretion in castrated adult rats (38, 39) . It has been well accepted that gonadotropin synthesis and GnRH receptor gene expression in the pituitary gonadotroph depend on the pulsatile pattern of GnRH signals (40) (41) (42) . Our recent study showed that the expression of Gnrhr and LHb in the anterior pituitary of Kiss1 KO rats, in which GnRH/LH pulses were diminished, was significantly lower than that of WT controls (14) . Taken together, the depression in LH responsiveness to a kisspeptin challenge in long-term EB-treated animals in the present study resulted from suppression of ARC kisspeptin expression, followed by suppression of pulsatile GnRH release, causing the pituitary malresponse to the kisspeptin challenge.
The results of the present study have demonstrated that both ERa and ERb mediate the suppressive effect of long-term estrogen in the developing brain, leading to irreversible inhibition of ARC Kiss1/kisspeptin expression. It is well known that ERa is coexpressed in ARC kisspeptin neurons and that ERa mediates estrogennegative regulation on ARC Kiss1/kisspeptin expression and subsequently LH pulses in adulthood (25, 43, 44) . The molecular mechanism mediating the ERa-dependent irreversible suppression of ARC Kiss1 expression induced by neonatal estrogen treatment is unclear. However, our previous results suggested that histone deacetylation at the Kiss1 promoter region is responsible for ERa-mediated reversible suppression of the ARC Kiss1 expression in adult mice (45) . A previous study showed that ERa KO female mice exhibited complete resistance to the chronic effects of neonatal DES (a synthetic estrogen) exposure on adult reproductive tracts, such as atrophy and epithelial squamous metaplasia in the uterus, proliferative lesions of the oviduct, and persistent cornification of the vaginal epithelium (46) . In addition, ERa is expressed in these tissues and hypothalamic ARC regions during the neonatal periods in rodents (47, 48) . ERa, therefore, plays a critical role in mediating the toxicological effects of neonatal estrogenization not only in female reproductive tracts (46) , but also in a hypothalamic reproductive center. In contrast, ERb expression was found in the ventromedial hypothalamic nucleus, medial preoptic area, and bed nucleus of the stria terminalis but not in the ARC during the neonatal period, such as days 3 and 7 in rats (49) . These findings suggest that neonatal estrogen might act on ERb located in these nuclei and consequently affect ARC kisspeptin neurons, causing suppression of ARC Kiss1 expression. Thus, the profound Kiss1 suppression induced by chronic EB exposure in WT mice could have resulted from the additive effects of estrogen mediated by ERa and ERb independently. In this context, the present neonatal EB treatment showed a tendency toward, but not statistically significant, decrease in the number of ARC Kiss1-expressing cells in both ERa KO and ERb KO mice.
The long-term neonatal EB treatment used in the present study failed to suppress ARC dopaminergic neurons, suggesting that the suppressive effect of neonatal estrogen on gene expression can occur in an ARC kisspeptin neuron-specific manner. The current EB treatment reduced the expression of both Tac3 and Pdyn, which are coexpressed in ARC kisspeptin neurons in mice (22) , rats (50) , ewes (51) , and goats (18) . It remains to be determined how ARC Kiss1 expression and Tac3 and Pdyn expression are reduced by neonatal estrogen; however, two possibilities could explain it. First, the present EB-induced suppression of Kiss1, Tac3, and Pdyn could be partly mediated by apoptosis of the neurons. This idea is consistent with the findings from a previous study showing that both Bax KO males and females had significantly more Kiss1-expressing neurons in the ARC than did WT animals (52) . The second possibility is that gene expression in ARC Kiss1 neurons is suppressed by persistent gene silencing. Lomniczi et al. (53) showed that polycomb group PcG of transcriptional silencers prevents premature initiation of puberty by silencing the Kiss1 gene in the kisspeptin neurons of the ARC in female rats. Therefore, disruption of these Kiss1 transcriptional regulations might be related to irreversible suppression of ARC Kiss1 expression in the animals in the present study that received neonatal EB treatment. Such a permanent change in gene expression was also found in the adult reproductive tract tissues after perinatal DES exposure. It has been demonstrated that neonatal DES exposure alters the expression of essential transcriptional regulators such as Wnt and Hox genes during the crucial period of uterine differentiation (54, 55) , resulting in urine developmental abnormalities. Furthermore, Li et al. (56) showed that gene expression of three epigenetic modifiers (DNMT3A, MBD2, and HDAC2) was increased in the seminal vesicle of neonatally estrogenized mice. Thus, these changes in transcriptional regulators or epigenetic modifiers induced by neonatal estrogenization might cause persistent gene silencing in adult animals. Further studies are required to clarify these points.
In conclusion, the present study has demonstrated that long-term exposure to supraphysiological doses of estrogen in the developing brain causes irreversible suppression of ARC kisspeptin expression via nuclear ERs and consequently suppresses pulsatile GnRH/LH release, resulting in reproductive malfunction in later life in female rodents. The present study provides a further understanding of the neuroendocrine mechanism, mediating the irreversible effects of estrogenic compounds and endocrine disrupting compounds at the developmental stages of female reproductive function, which have been reported in wildlife and humans (57) .
